Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03372291 · ClinicalTrials.gov registry record · NA
Psychological Intervention Mobile App for Patients With AML
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03372291: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03372291 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03372291, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This research study is evaluating the impact of a psychological intervention mobile application (app) on the quality of life, mood, and symptoms of patients with acute myeloid leukemia (AML).
Interventions
- OTHER Usual Care
- OTHER Psychological intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03372291
The ClinicalTrials.gov registry entry for NCT03372291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03372291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03372291 about?
NCT03372291 is a clinical study titled "Psychological Intervention Mobile App for Patients With AML". This research study is evaluating the impact of a psychological intervention mobile application (app) on the quality of life, mood, and symptoms of patients with acute myeloid leukemia (AML).
What is the current status of trial NCT03372291?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-09-01. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT03372291?
The interventions under investigation include: Usual Care (OTHER), Psychological intervention (OTHER).
Who is sponsoring clinical trial NCT03372291?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.